GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models-Reference-Cited by-同舟云学术

GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models

Published:2020-01 Issue:2 Volume:30 Page:381-396.e4
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Hanson Jesse E.,Ma Keran,Elstrott Justin,Weber Martin,Saillet Sandrine,Khan Abdullah S.,Simms Jeffrey,Liu Benjamin,Kim Thomas A.,Yu Gui-Qiu,Chen Yelin,Wang Tzu-Ming,Jiang Zhiyu,Liederer Bianca M.,Deshmukh Gauri,Solanoy Hilda,Chan Connie,Sellers Benjamin D.,Volgraf Matthew,Schwarz Jacob B.,Hackos David H.,Weimer Robby M.,Sheng Morgan,Gill T. Michael,Scearce-Levie Kimberly,Palop Jorge J.

Funder

Genentech

National Institutes of Health (NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference74 articles.

1. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue;Addis;Sci. Rep.,2017

2. Is the acute NMDA receptor hypofunction a valid model of schizophrenia?;Adell;Schizophr. Bull.,2012

3. Altered sleep homeostasis correlates with cognitive impairment in patients with focal epilepsy;Boly;Brain,2017

4. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice;Boyce-Rustay;Neuropsychopharmacology,2006

5. GRIN2A mutations cause epilepsy-aphasia spectrum disorders;Carvill;Nat. Genet.,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands;Acta Pharmaceutica Sinica B;2024-01

2. Targeting synapse function and loss for treatment of neurodegenerative diseases;Nature Reviews Drug Discovery;2023-11-27

3. Leukotriene A4 hydrolase inhibition improves age-related cognitive decline via modulation of synaptic function;Science Advances;2023-11-17

4. Pharmacological characterization of SAGE‐718, a novel positive allosteric modulator of N‐methyl‐d‐aspartate receptors;British Journal of Pharmacology;2023-11-13

5. Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice;Neuron;2023-11